Heska Corp (HSKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | HSKA | AKRO | LGND | ||
Company | Heska Corp | Akero Therapeutics Inc | Ligand Pharm | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 119.96 | 20.32 | 73.53 | ||
High | 120.03 | 20.75 | 74.17 | ||
Low | 119.96 | 19.63 | 72.57 | ||
Last | 119.99 | 19.66 | 73.90 | ||
Change | +0.05 | -0.05 | +1.58 | ||
% Change | +0.04% | -0.25% | +2.18% | ||
Volume | 394,400 | 543,500 | 141,700 | ||
20-Day Average Volume | 331,260 | 695,735 | 150,445 | ||
Previous Close | 119.94 | 19.71 | 72.32 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 118.10 | 20.94 | 74.83 | ||
20-Day Raw Stochastic | 99.13% | 26.26% | 44.11% | ||
20-Day Relative Strength | 73.88% | 37.86% | 50.42% | ||
Weighted Alpha | +51.30 | +5.03 | +0.19 | ||
Today's Opinion | 100% Buy | 72% Sell | 56% Buy | ||
Previous Opinion | 100% Buy | 72% Sell | 40% Buy | ||
Last Month's Opinion | 88% Buy | 40% Sell | 80% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.08% since 06/05/23 | -0.41% since 04/26/24 | +4.72% since 04/26/24 | ||
Low | 119.71 on 06/07/23 | 19.31 on 04/29/24 | 69.51 on 05/01/24 | ||
High | 120.03 on 06/12/23 | 20.75 on 05/03/24 | 74.17 on 05/03/24 | ||
1-Month | |||||
%Chg | +2.45% since 05/12/23 | -15.19% since 04/03/24 | -1.11% since 04/03/24 | ||
Low | 115.42 on 05/26/23 | 18.20 on 04/25/24 | 67.72 on 04/22/24 | ||
High | 120.03 on 06/12/23 | 23.89 on 04/04/24 | 81.73 on 04/12/24 | ||
3-Month | |||||
%Chg | +45.81% since 03/10/23 | -5.53% since 02/02/24 | -0.86% since 02/02/24 | ||
Low | 80.16 on 03/13/23 | 15.32 on 02/06/24 | 67.72 on 04/22/24 | ||
High | 120.03 on 06/12/23 | 37.00 on 03/04/24 | 94.57 on 02/27/24 | ||
6-Month | |||||
%Chg | +81.31% since 12/12/22 | +34.84% since 11/03/23 | +36.88% since 11/03/23 | ||
Low | 57.83 on 01/06/23 | 13.39 on 11/10/23 | 51.21 on 11/09/23 | ||
High | 120.03 on 06/12/23 | 37.00 on 03/04/24 | 94.57 on 02/27/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,309,570 | 1,359,509 | 1,308,399 | ||
Shares Outstanding, K | 10,914 | 69,151 | 17,705 | ||
Annual Sales | 257,310,000 | 0 | 131,310,000 | ||
Annual Net Income | -19,890,000 | -151,760,000 | 52,150,000 | ||
Last Quarter Sales | 62,380,000 | 0 | 28,100,000 | ||
Last Quarter Net Income | -10,130,000 | -55,190,000 | 18,190,000 | ||
60-Month Beta | 1.58 | -0.29 | 1.01 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.17 on 05/05/23 | -0.99 on 02/29/24 | 1.05 on 02/27/24 | ||
Latest Earnings Date | 05/08/23 | 05/20/24 | 05/07/24 | ||
Most Recent Dividend | 0.100 on 09/26/12 | N/A | 2.500 on 04/03/07 | ||
Next Ex-Dividends Date | 09/26/12 | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 315.63 | 0.00 | 15.86 |